REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Farmabla, Spol. S R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Farmabla, Spol. S R.O. Profile Updated: July 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Farmabla, Spol. S R.O. is an enterprise based in Slovakia. Its main office is in Presov. The company operates in the Pharmacies and Drug Stores sector. Farmabla, Spol. S R.O. was incorporated on August 11, 1994. The company’s latest financial report indicates a net sales revenue drop of 42.69% in 2024. Its’ total assets recorded a negative growth of 8.51%. In 2024, Farmabla, Spol. S R.O.’s net profit margin decreased by 1.23%.

Headquarters
Holleho, 3
Presov; Presovsky; Postal Code: 08001

Contact Details: Purchase the Farmabla, Spol. S R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Farmabla, Spol. S R.O. report to view the information.
Financial Auditors:
Purchase the Farmabla, Spol. S R.O. report to view the information.
Incorporation Date:
August 11, 1994
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
80.1%
Purchase this report to view the information.
19.9%
Company Performance
Financial values in the chart are available after Farmabla, Spol. S R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-42.69%▼
Total operating revenue
-42.67%▼
Operating profit (EBIT)
-69.19%▼
EBITDA
-69.19%▼
Net Profit (Loss) for the Period
-65.35%▼
Total assets
-8.51%▼
Total equity
-59.01%▼
Operating Profit Margin (ROS)
-1.72%▼
Net Profit Margin
-1.23%▼
Return on Equity (ROE)
-13.96%▼
Debt to Equity Ratio
-0.15%▼
Quick Ratio
-0.27%▼
Cash Ratio
-0.01%▼

Similar companies

Dr.Max 100 S.R.O.
 
Lekaren Rpt, S. R. O.
Benu Sk 77, S. R. O.
 
Lekaren Arcus, S.R.O.
Unizdrav Presov, S.R.O.
 
Z&T Pharma S.R.O.
Lekaren Viamila S.R.O.
 
Dr.Max 56 S.R.O.
Benu Sk 68, S.R.O.
 
Novio, S.R.O.
Cynex Medical S. R. O.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo